×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INKT – mink therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INKT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
03:00 pm
inkt
MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer
Low
Report
MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer
4/3
08:46 am
inkt
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 [Yahoo! Finance]
High
Report
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 [Yahoo! Finance]
4/3
08:14 am
inkt
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026 [Yahoo! Finance]
High
Report
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026 [Yahoo! Finance]
4/3
07:30 am
inkt
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
High
Report
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
4/2
07:30 am
inkt
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
Low
Report
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
4/1
08:01 am
inkt
MiNK Therapeutics (INKT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $35.00 price target on the stock.
Low
Report
MiNK Therapeutics (INKT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $35.00 price target on the stock.
4/1
07:48 am
inkt
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [TheStreet.com]
Low
Report
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [TheStreet.com]
4/1
07:45 am
inkt
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [Yahoo! Finance]
Low
Report
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/9
04:15 pm
inkt
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Orilall Melissa
Medium
Report
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Orilall Melissa
3/31
04:49 pm
inkt
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
Low
Report
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
3/31
08:07 am
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 31
Medium
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 31
3/27
10:40 am
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 27
Low
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 27
3/23
04:30 pm
inkt
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Charette Austin
Low
Report
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Charette Austin
3/19
05:21 pm
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 13
Low
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 13
3/11
06:22 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Mar 09 Filed by: Ryan Barbara
Medium
Report
Form 4 MiNK Therapeutics, Inc. For: Mar 09 Filed by: Ryan Barbara
3/4
04:45 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Feb 27 Filed by: Ryan Barbara
Low
Report
Form 4 MiNK Therapeutics, Inc. For: Feb 27 Filed by: Ryan Barbara
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: